HRTX Exercise Disclosure
Forbes William P · SEC Form 4 · Filed Nov 3, 2026
Exercise
Reported value range
Not reported
Forbes William P EVP, Chief Development Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
HRTX daily price context
Close on/before transaction
$0.28
Oct 30, 2026
First close after public filing
$0.28
Nov 3, 2026
Return after filing · so far
+2.92%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,770 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-444842
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.87K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 31, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Oct 31, 2026 | $931.56 |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 31, 2026 | $0 |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Oct 30, 2026 | $937.72 |
| Heron Therapeutics, Inc. /de/ HRTX Current | Exercise | Oct 30, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 30, 2026 | $0 |